Sonoma Pharmaceuticals

Historical price data

Sonoma Pharmaceuticals' mission is to commercialize its proprietary, stable hypochlorous acid technology as a safe and effective alternative to traditional antimicrobials and disinfectants. The company has achieved significant commercial traction, with its products approved and sold in over 50 countries, and has built a diversified portfolio spanning prescription wound care, OTC dermatology, and veterinary health. Its strategy focuses on expanding its commercial partnerships, growing its direct OTC e-commerce business, and pursuing new regulatory approvals to leverage its versatile platform across multiple high-value markets.

Patented, shelf-stable formulation of hypochlorous acid (HOCl) that mimics the body's natural immune response, providing a safe, non-toxic, broad-spectrum antimicrobial platform for therapeutic and disinfectant applications.

Sonoma competes with large incumbents in wound care (e.g., 3M), OTC dermatology (e.g., Johnson & Johnson), and disinfectants (e.g., Clorox). Its primary differentiation is the combination of proven efficacy and an exceptional safety profile, protected by patents on shelf-stable HOCl formulation.